MedicQuant ApS Financials, key figures and credit report
Gross profit 1 911.2 kDKK FY 2025 +74.6% vs 2024
EBIT -1 098.8 kDKK FY 2025 -4.3% vs 2024
Net debt - 936.5 kDKK FY 2025 +86.3% vs 2024
Quick ratio 5.9 FY 2025 -10.5 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 226.52 | -91.20 | 400.40 | 1 094.38 | 1 911.16 |
| Employee benefit expenses | - 149.05 | - 248.09 | -1 057.98 | -1 792.82 | -2 994.38 |
| Other operating expenses | - 190.42 | - 355.42 | |||
| Total depreciation | -15.55 | ||||
| EBIT | 77.47 | - 339.29 | - 848.00 | -1 053.86 | -1 098.77 |
| Other financial income | 0.00 | 32.89 | |||
| Other financial expenses | -2.46 | -1.81 | -10.15 | -1.65 | -10.73 |
| Pre-tax profit | 75.02 | - 341.10 | - 858.14 | -1 055.51 | -1 076.61 |
| Income taxes | 75.04 | -76.30 | 554.16 | 334.65 | |
| Net earnings | 75.02 | - 266.06 | - 934.44 | - 501.35 | - 741.96 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Development expenditure | 1 116.94 | 3 608.36 | 8 929.06 | ||
| Intangible rights | 20.00 | 20.00 | 20.00 | 14.00 | |
| Intangible assets total | 20.00 | 1 136.94 | 3 628.36 | 8 943.06 | |
| Machinery and equipment | 125.00 | 133.76 | |||
| Tangible assets total | 125.00 | 133.76 | |||
| Investments total | 66.78 | 120.49 | |||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 3.96 | 42.13 | |||
| Prepayments and accrued income | 8.67 | ||||
| Current other receivables | 25.43 | 146.28 | 184.96 | 153.47 | |
| Current deferred tax assets | 75.04 | 245.72 | 548.11 | 1 170.55 | |
| Short term receivables total | 8.67 | 100.47 | 395.97 | 775.20 | 1 324.02 |
| Cash and bank deposits | 302.00 | 91.21 | 10 341.52 | 6 851.30 | 936.53 |
| Cash and cash equivalents | 302.00 | 91.21 | 10 341.52 | 6 851.30 | 936.53 |
| Balance sheet total (assets) | 310.67 | 211.68 | 11 874.43 | 11 446.64 | 11 457.86 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 56.25 | 56.25 | 90.84 | 90.84 | 90.84 |
| Share premium account | 21.45 | 21.45 | 12 286.86 | 12 286.86 | 12 286.86 |
| Other reserves | 871.21 | 2 814.52 | 6 964.67 | ||
| Retained earnings | -8.68 | 66.34 | -1 070.93 | -3 948.68 | -8 600.18 |
| Profit of the financial year | 75.02 | - 266.06 | - 934.44 | - 501.35 | - 741.96 |
| Shareholders equity total | 144.04 | - 122.02 | 11 243.53 | 10 742.19 | 10 000.23 |
| Provisions | 246.98 | 240.93 | 1 076.84 | ||
| Non-current liabilities total | |||||
| Current trade creditors | 65.38 | 32.26 | 135.26 | 71.53 | |
| Other non-interest bearing current liabilities | 166.63 | 268.33 | 152.34 | 151.86 | 156.02 |
| Accruals and deferred income | 199.31 | 176.40 | 153.25 | ||
| Current liabilities total | 166.63 | 333.70 | 383.91 | 463.52 | 380.80 |
| Balance sheet total (liabilities) | 310.67 | 211.68 | 11 874.43 | 11 446.64 | 11 457.86 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated